Differences
This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
hdl_cholesterol [2025/01/27 17:32] – created admin | hdl_cholesterol [2025/01/28 05:21] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | |[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| | ||
+ | HDL Cholesterol Examination Procedure | ||
+ | **1.Purpose of examination: | ||
+ | HDL Cholesterol estimation from serum or plasma by Accelerator Selective Detergent method. | ||
- | Purpose of examination: | + | **2.Responsibility and Authority:** |
- | ●Triglyceride estimation from serum or plasma by Accelerator Selective Detergent method. | + | * Calibration: |
+ | * Quality Control: Technician | ||
+ | * Routine operation: Technician | ||
+ | * Overall Monitoring: Quality Manager | ||
- | Responsibility | + | **3.Sample Details:** |
- | ● Calibration: Technician | + | * Type of Sample: Serum, |
- | ● Quality Control: Technician | + | * Type of container |
- | ● Routine operation: Technician | + | * Patient Preparation: As per Primary Sample Collection Manual [[sample_collection_manual|]] |
- | ● Overall Monitoring: Quality Manager | + | * Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours |
+ | * Handling and transport: As per Primary Sample collection manual | ||
+ | * Storage: 24 hours at 2-8° C | ||
- | | + | **4.Required Equipment:** |
- | ● Type of Sample: Serum, | + | Centrifuge, Auto-Pipette, Disposable Tips, Disposable sample cups, FullyAuto Chemistry Analyzer |
- | ● Type of container and additives: Plain without any additives | + | |
- | ● Patient Preparation: | + | |
- | ● Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours | + | |
- | ● Handling and transport: As per Primary Sample collection manual | + | |
- | ● Storage: 24 hours at 2-8° C | + | |
- | Required Equipment: | + | **5.Required reagents:** |
- | ●Centrifuge, | + | |
- | + | ||
- | Required reagents: | + | |
R1: Cholesterol oxidase (E. coli) (< 1000 U/L), | R1: Cholesterol oxidase (E. coli) (< 1000 U/L), | ||
- | | + | Peroxidase (Horseradish) (< 1300 ppg U/L), |
- | N, N-bis (4-sulfobutyl)-m-toluidine-disodium (DSBmT) (< 1.0 mmol/L), | + | N, N-bis (4-sulfobutyl)-m-toluidine-disodium (DSBmT) (< 1.0 mmol/L), |
- | Accelerator (< 1.0 mmol/L), | + | Accelerator (< 1.0 mmol/L), |
- | Ascorbic oxidase (Cucurbita sp.) (< 3000 U/L). | + | Ascorbic oxidase (Cucurbita sp.) (< 3000 U/L). |
- | + | ||
- | | + | |
- | ● Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to settle at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles | + | |
- | Reagent Storage and stability | + | |
- | Unopened reagent stable at 2-8°C until expiration date. | + | |
- | On board System temperature reagent is stable for 28 days | + | |
- | Instability or deterioration should be suspected if there are precipitates, | + | |
- | contamination, | + | |
- | Calibration Procedure: | + | **6.Reagent Handling** |
- | ● Consolidated Chemistry Calibrator | + | * Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to settle at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles |
+ | * Reagent Storage and stability | ||
+ | * Unopened reagent stable at 2-8°C until expiration date. | ||
+ | * On board System temperature reagent is stable for 28 days | ||
+ | * Instability or deterioration should be suspected if there are precipitates, | ||
+ | * contamination, | ||
- | ● Frequency: | + | **7.Calibration Procedure: |
+ | * Consolidated Chemistry Calibrator | ||
+ | * Frequency: | ||
Reagent lot change | Reagent lot change | ||
QC out of range | QC out of range | ||
After service or maintenance | After service or maintenance | ||
Replacement in any parts of Instrument | Replacement in any parts of Instrument | ||
- | Procedure: | ||
- | Start the equipment.WDI abbotte fully.docx | ||
- | Calibrators are ready to use. | ||
- | Put calibrator 15-20 minutes at room temperature | ||
- | Prior to use, mix the contents by inverting the vial. Do not shake the vial to prevent foam formation. | ||
- | Take a 150 µl calibrator solution in separate aliquots. | ||
- | Go to the calibration and give the calibration order. | ||
- | Verify calibration with at least two levels of controls. | ||
- | If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary. | ||
- | Quality control | + | **Procedure:** |
- | Name: Bio Rad Level 1 & 2 | + | * Start the equipment.WDI abbotte fully.docx |
- | Frequency: As per Quality Control Procedure | + | * Calibrators are ready to use. |
- | ●Procedure for Reconstitution of IQC | + | * Put calibrator 15-20 minutes at room temperature |
- | Reconstitution of QC material with 5 ml Distilled water by using calibrated fixed volume pipette. | + | * Prior to use, mix the contents by inverting the vial. Do not shake the vial to prevent |
- | Leave to stand for 30 min in the dark place. | + | * Take a 150 µl calibrator solution in separate aliquots. |
- | Swirl gently several times during the reconstitution period | + | * Go to the calibration and give the calibration order. |
- | Prior to use, mix the contents by inverting the vial. Do not shake the vial as the information of foam should be avoided. Ensure that no lyophilized material remains un-reconstituted. | + | * Verify calibration with at least two levels of controls. |
- | Prepare aliquots of 150 µl from the reconstituted QC material. | + | * If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary. |
- | Store these aliquots | + | |
- | Prior to use, make sure that aliquots should | + | |
+ | **8.Quality control Procedure: | ||
+ | * Name: Bio Rad Level 1 & 2 | ||
+ | * Frequency: As per Quality Control Procedure | ||
+ | **Procedure for Reconstitution of IQC** | ||
+ | * Reconstitution of QC material with 5 ml Distilled water by using calibrated fixed volume pipette. | ||
+ | * Leave to stand for 30 min in the dark place. | ||
+ | * Swirl gently several times during the reconstitution period to ensure that the contents are completely dissolved. | ||
+ | * Prior to use, mix the contents by inverting the vial. Do not shake the vial as the information of foam should be avoided. Ensure that no lyophilized material remains un-reconstituted. | ||
+ | * Prepare aliquots of 150 µl from the reconstituted QC material. | ||
+ | * Store these aliquots at -15° C to -20° C. | ||
+ | * Prior to use, make sure that aliquots should be at room temperature for at least 15 min. | ||
- | ●Procedure to run IQC | + | **Procedure to run IQC** |
- | Press Control order | + | |
- | Select Assay /Panel, to be run. | + | |
- | Select the control/s and its level/s | + | |
- | Give Carrier Number and Position number | + | |
- | Press F3 / Add order | + | |
- | Put respected carrier in RSH rack | + | |
- | Check IQC results, in case outliers call residents. | + | |
- | Principle of the procedure used for examinations: | + | **9.Principle of the procedure used for examinations: |
- | This method is based on accelerating the reaction of cholesterol oxidase (CO) with non-HDL | + | |
unesterified cholesterol and dissolving HDL cholesterol selectively using a specific detergent. In the first reagent, non-HDL unesterified cholesterol is subject to an enzyme reaction and the peroxide generated is consumed by a peroxidase reaction with DSBmT yielding a colorless product. The second reagent consists of a | unesterified cholesterol and dissolving HDL cholesterol selectively using a specific detergent. In the first reagent, non-HDL unesterified cholesterol is subject to an enzyme reaction and the peroxide generated is consumed by a peroxidase reaction with DSBmT yielding a colorless product. The second reagent consists of a | ||
detergent (capable of solubilizing HDL cholesterol), | detergent (capable of solubilizing HDL cholesterol), | ||
- | Sample Preparation: | + | **10.Sample Preparation: |
- | ● Required SampleVolume: | + | |
- | ● Temperature: | + | |
Take 150-200µl of the sample from Primary tube to the secondary aliquot. Write the sample ID on the aliquot. | Take 150-200µl of the sample from Primary tube to the secondary aliquot. Write the sample ID on the aliquot. | ||
- | ●Procedure to run Patient sample | ||
- | Press Patient order | ||
- | Select Assay /Panel, to be run. | ||
- | Give Carrier Number and Position number | ||
- | Press F3 / Add order | ||
- | Put respected carrier in RSH rack | ||
- | Performance Characteristics: | + | **Procedure |
- | ● Linearity: up to 180 mg/dL | + | * Press Patient order |
- | ● The limit of detection (LOD): 5.0 mg/dL | + | * Select Assay /Panel, to be run. |
- | ● The limit of quantification(LOQ): | + | |
- | ● Unit: mg/dL | + | * Press F3 / Add order |
+ | * Put respected carrier in RSH rack | ||
+ | **11.Performance Characteristics: | ||
+ | * Linearity: up to 180 mg/dL | ||
+ | * The limit of detection (LOD): 5.0 mg/dL | ||
+ | * The limit of quantification(LOQ): | ||
+ | * Unit: mg/dL | ||
+ | **Normal and critical ranges:** | ||
- | | + | ^Parameter^Desirable / Optimal^Near/ |
+ | |HDL Cholesterol|> | ||
- | Parameter | + | **12.Laboratory Clinical interpretation: |
- | Desirable / Optimal | + | The principle role of HDL cholesterol in lipid metabolism is the uptake and transport of cholesterol from peripheral tissues to the liver through a process known as reverse cholesterol transport proposed cardioprotective mechanism).Low HDL cholesterol levels are strongly associated with an increased risk of coronary heart disease. |
- | Near/ Above optimal | + | |
- | Borderline | + | |
- | High | + | |
- | Very High | + | |
+ | **13.Interference and cross reaction:** | ||
+ | * No interference from Bilirubin up to32.6mg/dL | ||
+ | * No interference from Hemoglobin up to1000mg/ | ||
+ | * No interference from Intralipid up to1000 mg/dL | ||
+ | * No interference from Ascorbic acid up to 2.9mg/dl | ||
+ | **14.Potential source of variation: | ||
+ | - Turn around time (TAT): | ||
+ | - Routine: 6.0 hours | ||
+ | - Urgent: 2.0 hours | ||
- | HDL Cholesterol | + | **15.Recording of observation**: |
- | >60 mg/dL | + | Software backup |
+ | Machine raw data | ||
+ | **16.Storage & Disposal of waste:** Follow storage & discard procedure | ||
- | - | + | **17.Environmental & Safety control:** |
- | < 40 mg/dL | + | Reagent R1 contains sodium azide.contact with acids liberates very toxic gas |
- | - | + | |
+ | **18.Precautions: | ||
+ | * Wear protective gloves / protective clothing / eye protection | ||
+ | * Do not breathe mist / vapors / spray | ||
+ | * Wash hands thoroughly after handling | ||
+ | * Keep only in original container | ||
- | | + | **19.References: |
- | The principle role of HDL cholesterol in lipid metabolism is the uptake and transport of cholesterol from peripheral tissues to the liver through a process known as reverse cholesterol transport proposed cardioprotective mechanism).3 Low HDL cholesterol levels | + | |
- | are strongly associated with an increased risk of coronary heart disease. | + | |
- | + | ||
- | | + | |
- | + | ||
- | No interference from Bilirubin up to32.6mg/ | + | |
- | No interference from Hemoglobin up to1000mg/dL | + | |
- | No interference from Intralipid up to1000 mg/dL | + | |
- | No interference from Ascorbic acid up to 2.9mg/dl | + | |
- | + | ||
- | Potential source of variation: | + | |
- | Turn around time (TAT): | + | |
- | Routine: 6.0 hours | + | |
- | Urgent: 2.0 hours | + | |
- | + | ||
- | | + | |
- | Software backup | + | |
- | Machine raw data | + | |
- | Storage & Disposal of waste: Follow storage & discard procedure | + | |
- | Environmental & Safety control: | + | |
- | Reagent R1 contains sodium azide.contact with acids liberates very toxic gas | + | |
- | Precautions: | + | |
- | Wear protective gloves / protective clothing / eye protection | + | |
- | Do not breathe mist / vapors / spray | + | |
- | Wash hands thoroughly after handling | + | |
- | Keep only in original container | + | |
- | . | + | |
- | References: | + | |
US department of health and human services. Biosafety in MIcrobiological and biomedical laboratories. | US department of health and human services. Biosafety in MIcrobiological and biomedical laboratories. | ||
World health organization. Biosafety manual,3rd edition. | World health organization. Biosafety manual,3rd edition. | ||
Gotto AM. Lipoprotein metabolism and etiology of hyperlipidemia.Hosp pract 1988;23 | Gotto AM. Lipoprotein metabolism and etiology of hyperlipidemia.Hosp pract 1988;23 | ||
+ | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | ||
+ | |||
+ | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ||
+ | ^Document No.1^**Document Name**: HDL Cholesterol Examination Procedure^**Unique ID**:LSSTH /BIOCHEM/ SOP-5^^ | ||
+ | ^Issue No. : 01^Issue Date : | ||
+ | ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, | ||